Bhan Ishir, Thadhani Ravi
Department of Medicine, Renal Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Semin Nephrol. 2009 Jan;29(1):85-93. doi: 10.1016/j.semnephrol.2008.10.010.
Vitamin D has played a central role in the nephrologist's armamentarium, with active vitamin D analogues enjoying broad use for treatment of secondary hyperparathyroidism. Increasing data are now coming to light about the broader biological actions of vitamin D, including wide-ranging effects in several endocrine pathways, cardiovascular disease, infectious disease, and even the progression of chronic kidney disease (CKD). As additional agents are emerging to help with control of metabolic bone disease, these nontraditional pathways of vitamin D action will become increasingly important to consider when formulating a treatment plan. Although the only approved use for vitamin D analogues in CKD is the treatment of secondary hyperparathyroidism, well-conducted clinical trials may soon broaden the scope of this therapy. This article reviews the role of vitamin D therapy in CKD and looks to the answers that future research may bring.
维生素D在肾病专家的治疗手段中一直发挥着核心作用,活性维生素D类似物被广泛用于治疗继发性甲状旁腺功能亢进。现在,越来越多的数据揭示了维生素D更广泛的生物学作用,包括在多个内分泌途径、心血管疾病、传染病甚至慢性肾脏病(CKD)进展中的广泛影响。随着有助于控制代谢性骨病的其他药物不断涌现,在制定治疗方案时,这些维生素D作用的非传统途径将变得越来越重要。尽管维生素D类似物在CKD中唯一获批的用途是治疗继发性甲状旁腺功能亢进,但精心设计的临床试验可能很快会扩大这种疗法的应用范围。本文综述了维生素D疗法在CKD中的作用,并展望了未来研究可能带来的答案。